Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationTransplantation, AutologousHematologic NeoplasmsTransplantation ChimeraBone Marrow TransplantationStem CellsGraft vs Leukemia EffectTissue DonorsTreatment OutcomeMyeloablative AgonistsBusulfanGraft vs Tumor EffectVidarabineRecurrenceRemission InductionLymphocyte TransfusionGraft SurvivalImmunosuppressive AgentsHistocompatibility TestingRetrospective StudiesLeukemia, Myeloid, AcuteMultiple MyelomaLeukemiaCord Blood Stem Cell TransplantationSiblingsMinor Histocompatibility AntigensLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyWhole-Body IrradiationCytomegalovirus InfectionsLymphocyte DepletionHematopoietic Stem CellsHistocompatibilityDisease-Free SurvivalSurvival AnalysisSalvage TherapyAntilymphocyte SerumMyelodysplastic SyndromesLiver TransplantationSurvival RateVirus ActivationPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm, ResidualIncidenceChimerismMelphalanTime FactorsHepatic Veno-Occlusive DiseaseAcute DiseaseT-LymphocytesCyclophosphamideMesenchymal Stem Cell TransplantationAnemia, AplasticHematopoietic Stem Cell MobilizationAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusHLA AntigensFollow-Up StudiesCell TransplantationPrimary MyelofibrosisHematologic DiseasesKidney TransplantationTransplantation ImmunologyPrognosisEmbryonic Stem CellsAntigens, CD34ImmunosuppressionLeukemia, Myeloid, Accelerated PhaseAntibodies, NeoplasmCytarabineRoseolovirus InfectionsLymphoproliferative DisordersLeukemia, MyeloidImmunocompromised HostBenzamidesAdult Stem CellsAntineoplastic AgentsNuclear FamilyFusion Proteins, bcr-ablHodgkin DiseaseGraft RejectionReceptors, Purinergic P2X5InfectionPyrimidinesLeukocyte TransfusionGranulocyte Colony-Stimulating FactorGanciclovirLymphoma, Non-HodgkinRisk FactorsImmunotherapy, AdoptiveFatal OutcomeTransplantation, IsogeneicProspective StudiesPiperazinesCyclosporine